Private company
IVERIC bio
American pharmaceutical preparations company based in New York City. Summary from the record
Last updated Oct 19, 2026.
Overview
2007Founded1
- IndustryPharmaceutical Preparations1
- HeadquartersNew York City1
- Websitewww.ophthotech.com
- Legal formDelaware corporation1
- Incorporated inDE4
- Business address8 Sylvan Way, Parsippany, Nj 070544
- Filer categoryLarge accelerated filer4
- LEI549300GZXI59U71XPM703
- StatusActive3
- LEI statusLapsed (not renewed)3
- Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States3
- Registered withDivision of Corporations, Department of State, 42802663
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2019
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | $50.9M7 | $210.0M8 | $08 | $08 |
| Research and development | $196.3M7 | $66.3M8 | $41.7M9 | $39.6M6 |
| Operating expenses | ||||
| Operating income | -$195.6M7 | $108.0M8 | -$65.3M9 | -$61.3M6 |
| Income before tax | ||||
| Income tax | -$406.0K7 | -$4.7M8 | -$1.1M9 | -$111.0K6 |
| Net income | -$193.4M7 | $114.2M8 | $63.1M9 | -$58.9M6 |
| Earnings per share | -$5.457 | $3.188 | $1.709 | -$1.396 |
| Earnings per share (diluted) | -$5.457 | $3.178 | $1.709 | -$1.396 |
| Shares (weighted, basic) | ||||
| Shares (weighted, diluted) |
| Fiscal year | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Cash | $133.9M7 | $167.0M7 | $131.2M8 | $125.7M9 |
| Current assets | $295.9M13 | $171.5M7 | $133.3M8 | $128.6M9 |
| Property, plant and equipment | ||||
| Total assets | $299.6M13 | $175.6M7 | $137.2M8 | $130.2M9 |
| Current liabilities | $65.9M13 | $12.5M7 | $13.2M8 | $13.0M9 |
| Long-term debt | ||||
| Total liabilities | $394.2M13 | $137.5M7 | $13.2M8 | $13.0M9 |
| Retained earnings | ||||
| Shareholders’ equity | -$94.6M8 | $38.0M9 | $124.0M6 | $117.2M5 |
| Shares outstanding | 35.7M shares13 | 36.1M shares7 | 41.4M shares8 | 49.6M shares9 |
Leadership
Who has led IVERIC bio, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerGlenn Sblendorio Jul 5, 2017 to Jul 13, 202314
- Chief executive officerDavid R. Guyer Sep 24, 2013 to Feb 1, 201715
- ChairDavid R. Guyer Jul 5, 2017 to Dec 22, 202016
- PresidentPravin Dugel May 4, 2021 to Jul 13, 202317
- PresidentGlenn Sblendorio Feb 1, 2017 to Dec 22, 202018
- Chief financial officerDavid Francis Carroll Apr 25, 2017 to Jul 13, 202319
- Chief financial officerGlenn Sblendorio Apr 5, 2016 to Apr 4, 201720
- Chief financial officerMichael G. Atieh Oct 3, 2014 to Jan 5, 201621
- Chief financial officerBruce Peacock Sep 24, 2013 to Sep 4, 201422
- Chief operating officerKeith Westby Feb 1, 2017 to Jul 13, 202323
- Chief operating officerGlenn Sblendorio Apr 5, 2016 to Jan 19, 201720
Board members and other officers (19)
- Senior Vice President, CCOChristopher Paul Simms Aug 4, 2021 to Jul 13, 202324
- EVP, Chief Business OfficerAnthony S. Gibney Dec 15, 2021 to Jul 13, 202325
- EVP, Chief Strategy & BusinessPravin Dugel Jun 16, 2020 to Apr 5, 202126
- SVP, Gen. Counsel, SecretaryBarbara A. Wood Jan 5, 2018 to Jan 5, 201827
- SVP & CCOHenric Bjorn Bjarke Sep 2, 2015 to Jan 6, 201728
- Board memberPravin Dugel Jan 4, 2023 to Jul 13, 202329
- Board memberChristine Ann Miller Jan 7, 2022 to Jul 13, 202330
- Board memberMark S. Blumenkranz Jul 17, 2020 to Jul 13, 202331
- Board memberCalvin W. Roberts Jan 3, 2019 to Jul 13, 202332
- Board memberJane Henderson Jan 17, 2018 to Jul 13, 202333
- Board memberAdrienne L. Graves Dec 14, 2018 to Jul 13, 202334
- Board memberDavid E. Redlick Jan 6, 2016 to May 16, 201935
- Board memberIan F. Smith Aug 4, 2016 to Aug 4, 201636
- Board memberAxel Bolte Sep 24, 2013 to Jul 13, 202337
- Board memberDavid R. Guyer Sep 24, 2013 to Feb 1, 201715
- Board memberGlenn Sblendorio Sep 24, 2013 to Jul 13, 202338
- Board memberNicholas Galakatos Sep 25, 2013 to Jan 13, 201639
- Board memberThomas Dyrberg Oct 2, 2013 to Oct 25, 201340
- General counselBarbara A. Wood May 30, 2014 to Jan 4, 201841
Former names
- Ophthotech Corp.Aug 24, 2007 to Apr 11, 20194
Timeline
Filings
227 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 30 major events, 116 insider forms, 18 large holders, 56 other. The latest 20:
- Feb 14, 2024SC 13G/A EDGAR
- Jul 21, 202315-12G EDGAR
- Jul 17, 2023EFFECT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 13, 20234 OWNERSHIP DOCUMENT EDGAR
- Jul 11, 2023S-8 POS EDGAR
- Jul 11, 2023S-8 POS EDGAR
- Jul 11, 2023S-8 POS EDGAR
- Jul 11, 2023S-8 POS EDGAR
- Jul 11, 2023S-8 POS EDGAR
The 227 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
67 open-market trades by officers, directors and large owners since October 2021: 2 buys and 65 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 3, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $39.45 | $789.0K | Form 4 |
| Jun 2, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $37.87 | $757.4K | Form 4 |
| May 2, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $37.81 | $756.2K | Form 4 |
| May 1, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $37.12 | $742.4K | Form 4 |
| May 1, 2023 | Carroll David FrancisSVP, Chief Financial Officer | Sale | 63,500 | $37.04 | $2.4M | Form 4 |
| Apr 24, 2023 | Carroll David FrancisSVP, Chief Financial Officer | Sale | 48,171 | $30.21 | $1.5M | Form 4 |
| Apr 24, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 18,782 | $30.07 | $564.8K | Form 4 |
| Apr 21, 2023 | Carroll David FrancisSVP, Chief Financial Officer | Sale | 1,829 | $30.00 | $54.9K | Form 4 |
| Apr 21, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 1,218 | $30.00 | $36.5K | Form 4 |
| Apr 3, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 40,000 | $26.70 | $1.1M | Form 4 |
| Mar 2, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $23.93 | $478.6K | Form 4 |
| Feb 17, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 15,000 | $25.05 | $375.8K | Form 4 |
| Feb 2, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $23.82 | $476.4K | Form 4 |
| Feb 1, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 20,000 | $23.03 | $460.6K | Form 4 |
| Jan 3, 2023 | Westby KeithSVP, Chief Operating Officer | Sale | 3,480 | $20.06 | $69.8K | Form 4 |
| Jan 3, 2023 | SBLENDORIO GLENNChief Executive Officer | Sale | 17,447 | $20.06 | $350.0K | Form 4 |
| Jan 3, 2023 | Carroll David FrancisSVP, Chief Financial Officer | Sale | 3,602 | $20.06 | $72.3K | Form 4 |
| Jan 3, 2023 | Simms Christopher PaulSVP, Chief Commercial Officer | Sale | 2,368 | $20.06 | $47.5K | Form 4 |
| Dec 19, 2022 | SBLENDORIO GLENNChief Executive Officer | Sale | 19,457 | $21.51 | $418.5K | Form 4 |
| Dec 19, 2022 | Westby KeithSVP, Chief Operating Officer | Sale | 6,740 | $21.51 | $145.0K | Form 4 |
All 67 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Deep Track Capital, LPSC 13G/A, 3 filings Sep 16, 2022 to Feb 14, 202442
- Avidity Partners Management LPSC 13G/A, 3 filings Oct 25, 2021 to Feb 14, 202343
- Avoro Capital Advisors LLCSC 13G/A, 1 filing Feb 14, 202344
- PERCEPTIVE ADVISORS LLCSC 13G/A, 2 filings Feb 15, 2022 to Feb 14, 202345
- RTW INVESTMENTS, LPSC 13G/A, 1 filing Feb 14, 202346
- Vivo Capital IX, LLCSC 13G/A, 2 filings Feb 11, 2022 to Feb 14, 202347
- James E. FlynnSC 13G/A, 3 filings Feb 11, 2022 to Feb 10, 202348
- VANGUARD GROUP INCSC 13G, 1 filing Feb 9, 202349
- State Street CorporationSC 13G/A, 2 filings Feb 11, 2022 to Feb 3, 202350
Links
- Websitewww.ophthotech.com1
- WikidataQ30269231
- SEC EDGARCIK 1410939
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataIVERIC bio on Wikidata
- 2SEC EDGARIVERIC bio filings on SEC EDGAR
- 3
- 4SEC EDGARIVERIC bio filings on SEC EDGAR
- 5SEC EDGARIVERIC bio 10-K for fiscal 2019
- 6SEC EDGARIVERIC bio 10-K for fiscal 2019
- 7SEC EDGARIVERIC bio 10-K for fiscal 2016
- 8SEC EDGARIVERIC bio 10-K for fiscal 2017
- 9SEC EDGARIVERIC bio 10-K for fiscal 2018
- 10SEC EDGARIVERIC bio 10-Q for fiscal 2022
- 11SEC EDGARIVERIC bio 10-Q for fiscal 2022
- 12SEC EDGARIVERIC bio 10-Q for fiscal 2023
- 13SEC EDGARIVERIC bio 10-K for fiscal 2016
- 14
- 15
- 16SEC EDGARDavid R. Guyer, Chair
- 17SEC EDGARPravin Dugel, President
- 18SEC EDGARGlenn Sblendorio, President
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28SEC EDGARHenric Bjorn Bjarke, SVP & CCO
- 29SEC EDGARPravin Dugel, Board member
- 30SEC EDGARChristine Ann Miller, Board member
- 31SEC EDGARMark S. Blumenkranz, Board member
- 32SEC EDGARCalvin W. Roberts, Board member
- 33SEC EDGARJane Henderson, Board member
- 34SEC EDGARAdrienne L. Graves, Board member
- 35SEC EDGARDavid E. Redlick, Board member
- 36SEC EDGARIan F. Smith, Board member
- 37SEC EDGARAxel Bolte, Board member
- 38SEC EDGARGlenn Sblendorio, Board member
- 39SEC EDGARNicholas Galakatos, Board member
- 40SEC EDGARThomas Dyrberg, Board member
- 41SEC EDGARBarbara A. Wood, General counsel
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50